DOI QR코드

DOI QR Code

Clinical Characteristics and Outcome of Acute Heart Failure in Korea: Results from the Korean Acute Heart Failure Registry (KorAHF)

  • Lee, Sang Eun (Department of Internal Medicine, Seoul National University Hospital) ;
  • Lee, Hae-Young (Department of Internal Medicine, Seoul National University Hospital) ;
  • Cho, Hyun-Jai (Department of Internal Medicine, Seoul National University Hospital) ;
  • Choe, Won-Seok (Department of Internal Medicine, Seoul National University Hospital) ;
  • Kim, Hokon (Department of Internal Medicine, Seoul National University Hospital) ;
  • Choi, Jin Oh (Department of Internal Medicine, Sungkyunkwan University College of Medicine) ;
  • Jeon, Eun-Seok (Department of Internal Medicine, Sungkyunkwan University College of Medicine) ;
  • Kim, Min-Seok (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Jae-Joong (Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hwang, Kyung-Kuk (Department of Internal Medicine, Chungbuk National University College of Medicine) ;
  • Chae, Shung Chull (Department of Internal Medicine, Kyungpook National University College of Medicine) ;
  • Baek, Sang Hong (Department of Internal Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kang, Seok-Min (Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Choi, Dong-Ju (Department of Internal Medicine, Seoul National University Bundang Hospital) ;
  • Yoo, Byung-Su (Department of Internal Medicine, Yonsei University Wonju College of Medicine) ;
  • Kim, Kye Hun (Department of Internal Medicine, Heart Research Center of Chonnam National University) ;
  • Park, Hyun-Young (Division of Cardiovascular and Rare Diseases, Korea National Institute of Health) ;
  • Cho, Myeong-Chan (Department of Internal Medicine, Chungbuk National University College of Medicine) ;
  • Oh, Byung-Hee (Department of Internal Medicine, Seoul National University Hospital)
  • Received : 2016.11.28
  • Accepted : 2017.02.07
  • Published : 2017.05.31

Abstract

Background and Objectives: The burden of heart failure has increased in Korea. This registry aims to evaluate demographics, clinical characteristics, management, and long-term outcomes in patients hospitalized for acute heart failure (AHF). Subjects and Methods: We prospectively enrolled a total of 5625 consecutive subjects hospitalized for AHF in one of 10 tertiary university hospitals from March 2011 to February 2014. Descriptive statistics were used to determine the baseline characteristics of the study population and to compare them with those from other registries. Results: The mean age was $68.5{\pm}14.5$ years, 53.2% were male, and 52.2% had de novo heart failure. The mean systolic and diastolic blood pressures were $131.2{\pm}30.3mmHg$ and $78.6{\pm}18.8mmHg$ at admission, respectively. The left ventricular ejection fraction was ${\leq}40%$ in 60.5% of patients. Ischemia was the most frequent etiology (37.6%) and aggravating factor (26.3%). Angiotensin converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers, and aldosterone antagonists were prescribed in 68.8%, 52.2%, and 46.6% of the patients at discharge, respectively. Compared with the previous registry performed in Korea a decade ago, extracorporeal membrane oxygenation (ECMO) and heart transplantation have been performed more frequently (ECMO 0.8% vs. 2.8%, heart transplantation 0.3% vs. 1.2%), and in-hospital mortality decreased from 7.6% to 4.8%. However, the total cost of hospital care increased by 40%, and one-year follow-up mortality remained high. Conclusion: While the quality of acute clinical care and AHF-related outcomes have improved over the last decade, the long-term prognosis of heart failure is still poor in Korea. Therefore, additional research is needed to improve long-term outcomes and implement cost-effective care.

Keywords

Acknowledgement

Supported by : Korea Centers for Disease Control and Prevention

References

  1. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011;8:30-41. https://doi.org/10.1038/nrcardio.2010.165
  2. Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014;63:1123-33. https://doi.org/10.1016/j.jacc.2013.11.053
  3. Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011;123:933-44. https://doi.org/10.1161/CIR.0b013e31820a55f5
  4. Okura Y, Ramadan MM, Ohno Y, et al. Impending epidemic: future projection of heart failure in Japan to the year 2055. Circ J 2008;72:489-91. https://doi.org/10.1253/circj.72.489
  5. Curtis LH, Whellan DJ, Hammill BG, et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med 2008;168:418-24. https://doi.org/10.1001/archinternmed.2007.80
  6. Sato N, Kajimoto K, Asai K, et al. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data. Am Heart J 2010;159:949-55.e1. https://doi.org/10.1016/j.ahj.2010.03.019
  7. Fonarow GC, Heywood JT, Heidenreich PA, Lopatin M, Yancy CW; ADHERE Scientific Advisory Committee and Investigators. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007;153:1021-8. https://doi.org/10.1016/j.ahj.2007.03.012
  8. Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 2008;52:347-56. https://doi.org/10.1016/j.jacc.2008.04.028
  9. Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-36. https://doi.org/10.1093/eurheartj/ehl193
  10. West R, Liang L, Fonarow GC, et al. Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry. Eur J Heart Fail 2011;13:945-52. https://doi.org/10.1093/eurjhf/hfr064
  11. Choi DJ, Han S, Jeon ES, et al. Characteristics, outcomes and predictors of long-term mortality for patients hospitalized for acute heart failure: a report from the korean heart failure registry. Korean Circ J 2011;41:363-71. https://doi.org/10.4070/kcj.2011.41.7.363
  12. Francis GS, Cogswell R, Thenappan T. The heterogeneity of heart failure: will enhanced phenotyping be necessary for future clinical trial success? J Am Coll Cardiol 2014;64:1775-6. https://doi.org/10.1016/j.jacc.2014.07.978
  13. Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014;370:1383-92. https://doi.org/10.1056/NEJMoa1313731
  14. Kook HY, Jeong MH, Oh S, et al. Current trend of acute myocardial infarction in Korea (from the Korea Acute Myocardial Infarction Registry from 2006 to 2013). Am J Cardiol 2014;114:1817-22. https://doi.org/10.1016/j.amjcard.2014.09.019
  15. Ha KH, Kim DJ. Trends in the diabetes epidemic in Korea. Endocrinol Metab (Seoul) 2015;30:142-6. https://doi.org/10.3803/EnM.2015.30.2.142
  16. Jhun HJ, Kim H, Cho SI. Time trend and age-period-cohort effects on acute myocardial infarction mortality in Korean adults from 1988 to 2007. J Korean Med Sci 2011;26:637-41. https://doi.org/10.3346/jkms.2011.26.5.637
  17. Lee JH, Lim NK, Cho MC, Park HY. Epidemiology of heart failure in Korea: present and future. Korean Circ J 2016;46:658-64. https://doi.org/10.4070/kcj.2016.46.5.658
  18. Service KNHI [Internet]. 2014 Sep [cited 2016 October]. Available from: http://www.nhis.or.kr/bbs7/boards/B0039/3171.
  19. Han SW, Ryu KH, Chae SC, et al. Multicenter analysis of clinical characteristics and prognostic factors of patients with congestive heart failure in Korea. Korean Circ J 2005;35:357-61. https://doi.org/10.4070/kcj.2005.35.5.357
  20. Lee SE, Cho HJ, Lee HY, et al. A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry. Eur J Heart Fail 2014;16:700-8. https://doi.org/10.1002/ejhf.91
  21. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;37:2129-200. https://doi.org/10.1093/eurheartj/ehw128
  22. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005;149:209-16. https://doi.org/10.1016/j.ahj.2004.08.005
  23. Harjola VP, Follath F, Nieminen MS, et al. Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure. Eur J Heart Fail 2010;12:239-48. https://doi.org/10.1093/eurjhf/hfq002
  24. Chioncel O, Vinereanu D, Datcu M, et al. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J 2011;162:142-53. e1. https://doi.org/10.1016/j.ahj.2011.03.033
  25. McCullough PA, Hassan SA, Pallekonda V, et al. Bundle branch block patterns, age, renal dysfunction, and heart failure mortality. Int J Cardiol 2005;102:303-8. https://doi.org/10.1016/j.ijcard.2004.10.008
  26. Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur Heart J 2000;21:1246-50. https://doi.org/10.1053/euhj.1999.1985
  27. Maggioni AP, Anker SD, Dahlstrom U, et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC heart failure long-term registry. Eur J Heart Fail 2013;15:1173-84. https://doi.org/10.1093/eurjhf/hft134
  28. Lee HY, Chung WJ, Jeon HK, et al. Impact of the ${\beta}$-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between ${\beta}$ adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study. Korean J Intern Med 2016;31:277-87. https://doi.org/10.3904/kjim.2015.043

Cited by

  1. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction vol.104, pp.6, 2018, https://doi.org/10.1136/heartjnl-2017-311813
  2. Hyponatraemia and its prognosis in acute heart failure is related to right ventricular dysfunction vol.104, pp.20, 2018, https://doi.org/10.1136/heartjnl-2017-312084
  3. Effects of Widespread Inotrope Use in Acute Heart Failure Patients vol.7, pp.10, 2017, https://doi.org/10.3390/jcm7100368
  4. Comparison of Characteristics and 3-Year Outcomes in Patients With Acute Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction vol.83, pp.2, 2017, https://doi.org/10.1253/circj.cj-18-0543
  5. Fimasartan for Remodeling after Myocardial Infarction vol.8, pp.3, 2017, https://doi.org/10.3390/jcm8030366
  6. Artificial intelligence algorithm for predicting mortality of patients with acute heart failure vol.14, pp.7, 2017, https://doi.org/10.1371/journal.pone.0219302
  7. Prognostic Implication of Ventricular Conduction Disturbance Pattern in Hospitalized Patients with Acute Heart Failure Syndrome vol.49, pp.7, 2019, https://doi.org/10.4070/kcj.2018.0290
  8. Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway vol.49, pp.7, 2019, https://doi.org/10.4070/kcj.2018.0379
  9. The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction vol.34, pp.5, 2019, https://doi.org/10.3904/kjim.2018.009
  10. Heart failure awareness in the Korean general population: Results from the nationwide survey vol.14, pp.9, 2019, https://doi.org/10.1371/journal.pone.0222264
  11. Predicting stroke and death in patients with heart failure using CHA2DS2-VASc score in Asia vol.19, pp.1, 2017, https://doi.org/10.1186/s12872-019-1178-0
  12. Hyponatremia in Heart Failure: Pathogenesis and Management vol.15, pp.4, 2017, https://doi.org/10.2174/1573403x15666190306111812
  13. Prognostic Value of Cystatin C-Derived Estimated Glomerular Filtration Rate in Patients with Acute Heart Failure vol.10, pp.4, 2017, https://doi.org/10.1159/000504084
  14. Admission Hyperglycemia as a Predictor of Mortality in Acute Heart Failure: Comparison between the Diabetics and Non-Diabetics vol.9, pp.1, 2017, https://doi.org/10.3390/jcm9010149
  15. Characteristics and outcomes of HFpEF with declining ejection fraction vol.109, pp.2, 2017, https://doi.org/10.1007/s00392-019-01505-y
  16. Guideline-directed medical therapy in elderly patients with heart failure with reduced ejection fraction: a cohort study vol.10, pp.2, 2020, https://doi.org/10.1136/bmjopen-2019-030514
  17. Neutrophil-Lymphocyte Ratio in Patients with Acute Heart Failure Predicts In-Hospital and Long-Term Mortality vol.9, pp.2, 2017, https://doi.org/10.3390/jcm9020557
  18. Global Differences in Characteristics, Precipitants, and Initial Management of Patients Presenting With Acute Heart Failure vol.5, pp.4, 2017, https://doi.org/10.1001/jamacardio.2019.5108
  19. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction vol.106, pp.15, 2017, https://doi.org/10.1136/heartjnl-2019-316219
  20. The Lebanese Heart Failure Snapshot: A National Presentation of Acute Heart Failure Admissions vol.52, pp.5, 2017, https://doi.org/10.1111/jnu.12583
  21. Mega‐trials in heart failure: effects of dilution in examination of new therapies vol.22, pp.9, 2020, https://doi.org/10.1002/ejhf.1780
  22. Predictive Factors on the Incidence of Heart Failure in Patients with Ischemic Heart Disease: Using a 10-Year Population-Based Korea National Health Insurance Cohort Data vol.17, pp.22, 2017, https://doi.org/10.3390/ijerph17228670
  23. Association Between Symptoms of Patients With Heart Failure and Patient Outcomes Based on Electronic Nursing Records vol.39, pp.12, 2021, https://doi.org/10.1097/cin.0000000000000763
  24. Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes vol.45, pp.2, 2021, https://doi.org/10.4093/dmj.2020.0282
  25. Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers : Analysis of Data From the KAMIR-NIH Registry vol.14, pp.4, 2017, https://doi.org/10.1161/circinterventions.120.010159
  26. Heart failure and atrial fibrillation: tachycardia‐mediated acute decompensation vol.8, pp.4, 2017, https://doi.org/10.1002/ehf2.13354
  27. Prognostic impact of chromogranin A in patients with acute heart failure vol.38, pp.4, 2017, https://doi.org/10.12701/yujm.2020.00843
  28. Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction vol.10, pp.22, 2017, https://doi.org/10.1161/jaha.121.021414
  29. Impact of insulin therapy on the mortality of acute heart failure patients with diabetes mellitus vol.20, pp.1, 2017, https://doi.org/10.1186/s12933-021-01370-y
  30. Hypertensive Heart Failure in Asia vol.9, pp.3, 2017, https://doi.org/10.1159/000518661